A collaborative leader, Elaine Haynes leadership style was forged in the crucible of large pharma and sharpened as CEO of Baltimore-based artificial red blood cell startup, KaloCyte.

By Alex Keown | September 27, 2023

Throughout her three decades in the biopharma industry, KaloCyte Chief Executive Officer Elaine Haynes has garnered a significant amount of experience in various leadership roles that have shaped her own outlook as the head of an artificial red blood cell startup company in the BioHealth Capital Region.

Haynes spent the majority of her career at Mallinckrodt Pharmaceuticals, first working as a nuclear pharmacist, then in various roles of increasing responsibility. In her last role at Mallinckrodt, as Vice President of Alliance Management and External Partnering, Haynes was tasked with overseeing the divestiture of several divisions of the company. Mallinckrodt had decided the divisions were no longer a strategic fit for the company and needed to be sold off, she said.

It was a difficult task. Not only did it involve the elimination of colleagues she had worked alongside for years, ultimately it meant the elimination of her own job. The time winding down those divisions was a crucible for leadership training.

Read the full story from BioBuzz.